Ying Xu

Ying Xu

Auto-generated profile, based on publicly available information

Ying Xu

Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2023 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
YXYing Xu
Ying Xu
WLWenting Li
Wenting Li
JGJianhe Gan
Jianhe Gan
XHXuefeng He
Xuefeng He
XHXiaoping Huang
Xiaoping Huang

13 February 2025 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
YXYing Xu
Ying Xu
YYYufeng Yin
Yufeng Yin
WLWenting Li
Wenting Li
JZJin Zhou
Jin Zhou
YWYan Wang
Yan Wang
XHXiaoping Huang
Xiaoping Huang

9 November 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
CXChuancai Xu
Chuancai Xu
ZHZhisong He
Zhisong He
WLWei Lei
Wei Lei
LCLi Chen
Li Chen
DSDan Shen
Dan Shen
JHJian-an Huang
Jian-an Huang
At present, the role of inactivated vaccines in viral RNA shedding among Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) breakthrough infections is still unknown. We collected data of 147 coronavirus disease 2019 (COVID-19) patients with mild-to-moderate illness who were hospitalized in the Third People’s Hospital of Yangzhou from 7 to 20 August 2021 and analyzed the differences in symptoms and laboratory tests among fully vaccinated (FV), partially vaccinated (PV) and unvaccinated (UV) patients. The median duration of viral RNA shedding was shorter in the FV (12 [IQR, 9.5–14] days) and PV (13 [IQR, 9–16.75] days) groups than in the UV group (15 [IQR, 11.75–17.25] days) (adjusted P < 0.001 and adjusted P = 0.23, respectively). The median titers of SARS-CoV-2-specific IgG and IgM were significantly higher in the FV (12.29 S/co [IQR, 2.08–63.59] and 0.3 S/co [IQR, 0.05–2.29], respectively) and PV (0.68 S/co [IQR, 0.14–28.69] and 0.12 S/co [0.03–5.23], respectively) groups than in the UV group (0.06 S/co [IQR, 0.03–0.47] and 0.04 S/co [IQR, 0.02–0.07]) (adjusted P < 0.001 and adjusted P = 0.008, respectively). Inactivated vaccines may shorten viral RNA shedding in breakthrough infected patients who have mild-to-moderate illness and may improve the ability of the host to generate specific antibodies to infection.

5 December 2025 in Medicine
Verified
Journal Article
Open access
YWYan Wang
Yan Wang
LCLi Chen
Li Chen
WSWei Sun
Wei Sun
WLWenting Li
Wenting Li
YXYing Xu
Ying Xu
JGJianhe Gan
Jianhe Gan
Hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF) is a severe clinical syndrome with a high mortality rate. Identifying prognostic factors is therefore crucial. This study aimed to identify factors influencing the prognosis of HBV-ACLF and to construct a combined prognostic indicator. This retrospective study included 258 patients with HBV-ACLF, categorized into 2 groups based on prognosis: improvement and worsening. Baseline characteristics, biochemical parameters, and hematological indicators were compared between the 2 groups. Multiple logistic regression and a support vector machine model were applied to analyze the factors associated with prognosis. Based on the regression results, a composite indicator was developed and its predictive performance was evaluated using receiver operating characteristic curve analysis. The incidence of complications such as advanced age, esophageal varices, severe jaundice, and severe ascites was significantly higher in the prognosis worsening group than in the improvement group. Biochemical and hematological indicators such as ammonia (NH₃), lactate dehydrogenase (LDH), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were significantly elevated in the worsening group, while albumin levels were significantly lower compared with the improvement group. Analysis indicated that ALT, AST, LDH, NH₃, and model for end-stage liver disease score were most strongly associated with prognosis. The receiver operating characteristic curve of the combined indicator showed an area under the curve of 0.749, outperforming any single indicator. In addition, the combined index was significantly negatively correlated with the length of hospital stay. ALT, AST, LDH, NH₃, and model for end-stage liver disease score are key prognostic factors in patients with HBV-ACLF. The combined indicator constructed from these variables demonstrates good predictive value for clinical outcomes and length of hospital stay, and may provide useful guidance for clinical decision-making.

1 August 2021 in SCIENTIA SINICA Vitae
Verified
Journal Article
Open access
JZJunling Zhuang
Junling Zhuang
BHBing Han
Bing Han
MCMiao Chen
Miao Chen
Xuan WangXuan Wang
Xuan Wang
CYChen Yang
Chen Yang
DZDao-bin Zhou
Dao-bin Zhou
阵发性睡眠性血红蛋白尿症(PNH)是一种罕见后天获得的克隆性造血干细胞(HSC)疾病。发病机制为磷脂酰肌醇聚糖A(PIGA)基因突变导致细胞膜上锚连蛋白糖基磷脂酰肌醇(GPI)异常,从而使各种血细胞遭受补体攻击破坏。发作性溶血和慢性贫血是最常见临床表现,也可出现多系血细胞减少为表现的的骨髓衰竭。血栓形成是PNH的主要并发症及死亡原因之一。早期治疗仅为输血支持,补体C5单克隆抗体成为经典PNH治疗中的突破性药物,异基因造血干细胞移植是唯一可能治愈PNH的方法。北京协和医院是国内最早报道PNH病例的单位,也是国内不断改进PNH检测方法的领先中心。临床和基础研究团队长期积累,建立了国内最大PNH队列,在探索PNH骨髓衰竭和血栓发生机制等方面成为国内引领。在北京协和医院建院百年之际,本文回顾历史,总结协和及国内血液人在PNH上的临床和研究经验,以期传承老一辈的钻研精神,进一步提高PNH诊治水平。

9 February 2023 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
CXChuan‐Cai Xu
Chuan‐Cai Xu
ZHZhi‐Song He
Zhi‐Song He
WLWei Lei
Wei Lei
JZJin‐Zhou Zhu
Jin‐Zhou Zhu
DZDa‐Guo Zhao
Da‐Guo Zhao
JHJian-an Huang
Jian-an Huang
Background: Understanding of the early immune response in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) breakthrough infections is limited.Methods: Ninety‐eight patients with coronavirus disease 2019 (COVID‐19) breakthrough infections were divided into two groups, with intervals from receiving the second dose of inactivated vaccine to the onset of illness <60 or ≥60 days.Results: The median lymphocyte count and the median anti‐SARS‐CoV‐2 spike immunoglobulin G (IgG) and immunoglobulin M (IgM) titers were higher in the <60‐day interval group compared with the corresponding medians in the ≥60‐day interval group (p = 0.005, p = 0.001, and p = 0.001, respectively). The median interleukin‐6 (IL‐6) level in the <60‐day interval group was significantly lower than the median IL‐6 level in the ≥60‐day interval group (p < 0.001).Conclusions: Our results highlight the different anti‐SARS‐CoV‐2 spike IgG and IgM antibody titers among patients with different intervals from receiving the second dose of inactivated vaccine to the onset of illness.